A detailed history of Brucke Financial, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Brucke Financial, Inc. holds 1,140 shares of LLY stock, worth $1.16 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
1,140
Previous 1,087 4.88%
Holding current value
$1.16 Million
Previous $848 Million 16.09%
% of portfolio
0.58%
Previous 0.59%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$625.65 - $812.69 $33,159 - $43,072
53 Added 4.88%
1,140 $984 Million
Q2 2025

Jul 24, 2025

SELL
$713.71 - $898.95 $13,560 - $17,080
-19 Reduced 1.72%
1,087 $848 Million
Q1 2025

May 07, 2025

SELL
$725.72 - $929.72 $7,982 - $10,226
-11 Reduced 0.98%
1,106 $995 Million
Q4 2024

Feb 27, 2025

BUY
$727.2 - $932.06 $812,282 - $1.04 Million
1,117 New
1,117 $906 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Brucke Financial, Inc. Portfolio

Follow Brucke Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brucke Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brucke Financial, Inc. with notifications on news.